Skip to main content
. 2017 Nov 30;8(67):111396–111404. doi: 10.18632/oncotarget.22802

Table 2. Detailed illustration of the EORTC subscales future uncertainty (FU), global health (GH) and quality of life (QoL) including significant findings.

QoL (n=229) p- Value GH
(n=217)
p-Value FU (n=96) p- Value
n/ (%) n/ (%) n/ (%)
Diagnosis
malignant 127(55.5) 0,533 116 (53.5) 0,774 65 (67.7) 0,003
benign 102 (44.5) 101 (46.5) 31 (32.3)
prim. diagnosis 160(69.9) 0,907 152 (70) 0,983 63 (65.6) 0,337
recurrent disease 69 (30.1) 65 (30) 33 (34.4)
Age (years) median
<65 years 161(70.3) 0,736 156 (71.9) 0,244 71 (74) 0,328
>65 years 68 (29.7) 61 (28.1) 25 (26)
male 100 (43.7) 0,018 96 (44.2) 0,022 33 (34.4) 0,001
female 129 (56.3) 121 (55.7) 63 (65.6)
partnership
yes 177 (77.3) 0,782 171 (78.8) 0,679 72 (75) 0,678
no 52 (22.7) 46 (21.2) 24 (25)
children
yes 161 (70.3) 0,809 154 (71) 0,923 74 (77.1) 0,199
no 68 (29.7) 63 (29) 22 (22.9)
Pre-existing psychiatric disorders
yes 61 (26.6) 0,132 59 (27.2) 0,025 33 (34.4) 0,006
no 168 (73.4) 158 (72.8) 63 (65.6)
ataractics
yes 62 (27.1) 0,001 60 (27.6) 0,002 32 (33.3) 0,001
no 167 (72.9) 157 (72.4) 64 (66.7)